AU6903800A - Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders - Google Patents
Novel protein phosphatases and diagnosis and treatment of phosphatase-related disordersInfo
- Publication number
- AU6903800A AU6903800A AU69038/00A AU6903800A AU6903800A AU 6903800 A AU6903800 A AU 6903800A AU 69038/00 A AU69038/00 A AU 69038/00A AU 6903800 A AU6903800 A AU 6903800A AU 6903800 A AU6903800 A AU 6903800A
- Authority
- AU
- Australia
- Prior art keywords
- phosphatase
- diagnosis
- treatment
- related disorders
- novel protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03016—Phosphoprotein phosphatase (3.1.3.16), i.e. calcineurin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14900599P | 1999-08-13 | 1999-08-13 | |
US60149005 | 1999-08-13 | ||
PCT/US2000/022158 WO2001012819A2 (en) | 1999-08-13 | 2000-08-11 | Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6903800A true AU6903800A (en) | 2001-03-13 |
Family
ID=22528389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU69038/00A Abandoned AU6903800A (en) | 1999-08-13 | 2000-08-11 | Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1212433A2 (en) |
JP (1) | JP2003507016A (en) |
AU (1) | AU6903800A (en) |
CA (1) | CA2377662A1 (en) |
WO (1) | WO2001012819A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4367600A (en) * | 1999-07-02 | 2001-01-22 | Ceptyr, Inc. | Dsp-3 dual-specificity phosphatase |
US7504223B2 (en) * | 1999-08-05 | 2009-03-17 | Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Knockout mouse for the tumor suppressor gene ANX7 |
US6420153B1 (en) | 2000-02-29 | 2002-07-16 | Millennium Pharmaceuticals, Inc. | 18232, a novel dual specificity phosphatase and uses therefor |
EP1268818A2 (en) * | 2000-03-24 | 2003-01-02 | Millennium Pharmaceuticals, Inc. | 18221, dual specificity phosphatase and uses thereof |
WO2002010363A2 (en) * | 2000-07-28 | 2002-02-07 | Incyte Genomics, Inc. | Protein phosphatases |
AU2002212164A1 (en) * | 2000-09-07 | 2002-03-22 | Bayer Aktiengesellschaft | Regulation of human map kinase phosphatase-like enzyme |
AU2001291824A1 (en) * | 2000-09-11 | 2002-03-22 | Bayer Aktiengesellschaft | Regulation of human tyrosine phosphatase-like enzyme |
US6825021B2 (en) * | 2000-09-19 | 2004-11-30 | Ceptyr, Inc. | DSP-15 dual-specificity phosphatase |
JP2004514434A (en) * | 2000-11-20 | 2004-05-20 | ピーイー コーポレーション (エヌワイ) | Isolated human phosphatase protein, nucleic acid molecule encoding human phosphatase protein and uses thereof |
MXPA03005436A (en) | 2000-12-20 | 2004-05-05 | Bristol Myers Squibb Co | Polynucleotides encoding novel human phosphatases. |
WO2002090530A2 (en) * | 2001-01-18 | 2002-11-14 | Incyte Genomics, Inc. | Kinases and phosphatases |
JPWO2003038118A1 (en) * | 2001-10-31 | 2005-02-24 | 藤沢薬品工業株式会社 | Method for evaluating phosphatase inhibitor |
WO2003044161A2 (en) * | 2001-11-15 | 2003-05-30 | Tularik Inc. | Gene amplification and overexpression in cancer |
AU2003212162A1 (en) * | 2002-03-28 | 2003-10-13 | Qlt Inc. | Cancer associated protein phosphatases and their uses |
WO2004028554A2 (en) * | 2002-09-27 | 2004-04-08 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Skrp, astray, string, vacm associated with metabolic control |
GB2465907B (en) | 2007-08-10 | 2013-07-10 | Agency Science Tech & Res | VHZ for diagnosis and treatment of cancer |
US9580513B2 (en) | 2008-08-08 | 2017-02-28 | Agency For Science, Technology And Research (A*Star) | VHZ for diagnosis and treatment of cancers |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8479498A (en) * | 1997-07-08 | 1999-02-08 | Cold Spring Harbor Laboratory | Dual specificity phosphatase and methods of use |
WO2000006728A2 (en) * | 1998-07-28 | 2000-02-10 | Incyte Pharmaceuticals, Inc. | Phosphorylation effectors |
AU6410599A (en) * | 1998-09-30 | 2000-04-17 | Millennium Pharmaceuticals, Inc. | Novel protein phosphatase molecules and uses therefor |
EP1192257A2 (en) * | 1999-03-18 | 2002-04-03 | Incyte Pharmaceuticals, Inc. | Human regulators of intracellular phosphorylation |
US6852520B1 (en) * | 1999-03-24 | 2005-02-08 | Ceptyr, Inc. | DSP-2 dual-specificity phosphatase |
CA2367104A1 (en) * | 1999-04-07 | 2000-10-12 | Ceptyr, Inc. | Dsp-7 dual-specificity map kinase phosphatase |
AU4213100A (en) * | 1999-04-07 | 2000-10-23 | Ceptyr, Inc. | Dsp-4 dual-specificity map kinase phosphatase |
AU4470200A (en) * | 1999-04-20 | 2000-11-02 | Ceptyr, Inc. | Dsp-8 dual-specificity map kinase phosphatase |
EP1173587A1 (en) * | 1999-04-23 | 2002-01-23 | Ceptyr, Inc. | Dsp-10 dual-specificity map kinase phosphatase |
US6645753B1 (en) * | 1999-04-27 | 2003-11-11 | Ceptyr, Inc. | DSP-5 dual-specificity phosphatase |
AU4367600A (en) * | 1999-07-02 | 2001-01-22 | Ceptyr, Inc. | Dsp-3 dual-specificity phosphatase |
US6649391B1 (en) * | 1999-07-20 | 2003-11-18 | Ceptyr, Inc. | DSP-11 dual-specificity phosphatase |
CA2383927A1 (en) * | 1999-09-15 | 2001-03-22 | Incyte Genomics, Inc. | Protein phosphatase and kinase proteins |
-
2000
- 2000-08-11 WO PCT/US2000/022158 patent/WO2001012819A2/en not_active Application Discontinuation
- 2000-08-11 CA CA002377662A patent/CA2377662A1/en not_active Abandoned
- 2000-08-11 AU AU69038/00A patent/AU6903800A/en not_active Abandoned
- 2000-08-11 EP EP00957413A patent/EP1212433A2/en not_active Withdrawn
- 2000-08-11 JP JP2001516906A patent/JP2003507016A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2001012819A3 (en) | 2002-01-24 |
EP1212433A2 (en) | 2002-06-12 |
CA2377662A1 (en) | 2001-02-22 |
WO2001012819A2 (en) | 2001-02-22 |
JP2003507016A (en) | 2003-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
AU2002252373A1 (en) | Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders | |
AU6903800A (en) | Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders | |
AUPQ415899A0 (en) | Compositions for and methods of treatment of allergic diseases | |
AU5840200A (en) | Treatment of diabetes and related pathologies | |
AU6205700A (en) | Azo amino acid derivatives for the treatment of neurological diseases | |
AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
AU9551298A (en) | Use of coumarin derivatives for the treatment of digestive tract disorders | |
AU1356201A (en) | Treatment of hyperproliferative disorders | |
AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
AU5908300A (en) | Prevention and treatment of amyloid-associated disorders | |
AU3896900A (en) | Treatment of pain | |
AUPQ201499A0 (en) | Treatment of inflammatory and malignant diseases | |
GB2361872B (en) | Diagnosis of medical disorders | |
AU7106300A (en) | Treatment of skin disorders | |
AU5550800A (en) | Diagnosis and treatment of alzheimer's disease | |
AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
AU4215499A (en) | Treatment of neurodegenerative diseases | |
AU2432001A (en) | Treatment of mental conditions including depression | |
AU7260098A (en) | Diagnosis and treatment of phosphatase 0r kinase-related disorders | |
AU3899100A (en) | Treatment of hyperactivity disorders | |
AU1405001A (en) | Treatment of diseases | |
AU2001258575A1 (en) | Treatment of cancer and neurological diseases | |
GB9908059D0 (en) | Diagnosis and treatment of diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |